Article Information
History
- August 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Franziska Hielscher1,
- Tina Schmidt, PhD1,
- Verena Klemis1,
- Alexander Wilhelm2,
- Stefanie Marx1,
- Amina Abu-Omar1,
- Laura Ziegler1,
- Candida Guckelmus1,
- Rebecca Urschel1,
- Urban Sester, MD3,
- Marek Widera, PhD2 and
- Martina Sester, PhD1,*
- 1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
- 2Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- 3Department of Nephrology, SHG-Klinikum Völklingen
- ↵*Correspondence: Martina Sester, PhD, Saarland University, Department of Transplant and Infection Immunology, Institutes of Infection Medicine, building 47, Kirrberger Straße, D-66421 Homburg, Germany; email: martina.sester{at}uks.eu
Posted August 03, 2022.
Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
